Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News WisdomTree India Earnings Fund EPI

The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree India Earnings Index. Under normal circumstances, at least 95% of the funds total assets (exclusive of collateral held from securities lending) will be invested in component securities of the index and investments that have economic characteristics that are substantially identical to the... see more

Recent & Breaking News (ARCA:EPI)

ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit

Canada NewsWire September 21, 2020

ESSA Pharma Provides Business Update and Announces Financial Results for the Fiscal Third Quarter Ended June 30, 2017

Canada NewsWire August 14, 2017

E-Trade Adds To Commission-Free ETF Suite

Benzinga.com  August 11, 2017

ESSA Pharma Provides Further Update on Proposed Equity Offering

Canada NewsWire July 24, 2017

ESSA Pharma Announces Receipt of NASDAQ Notice of Market Value Deficiency

Canada NewsWire July 21, 2017

ESSA Pharma Announces Receipt of NASDAQ Notice of Bid Price Deficiency

Canada NewsWire July 20, 2017

ESSA Pharma Announces Update to Proposed Equity Offering

Canada NewsWire July 18, 2017

IIROC Trade Resumption - EPI

Canada NewsWire July 13, 2017

IIROC Trade Resumption - ESSA Pharma Inc.

Newsfile July 13, 2017

ESSA Pharma Announces Pricing Of Proposed Equity Offering

Canada NewsWire July 13, 2017

IIROC Trading Halt - EPI

Canada NewsWire July 12, 2017

ESSA Pharma Announces Overnight Marketed Equity Offering

Canada NewsWire July 12, 2017

IIROC Trade Halt - ESSA Pharma Inc.

Newsfile July 12, 2017

ESSA Pharma Presents Data From Phase 1 Trial of EPI-506 at 2017 ASCO Annual Meeting

Canada NewsWire June 5, 2017

ESSA Pharma Announces Data from Phase 1 Trial of EPI-506 to be Presented During 2017 ASCO Annual Meeting

Canada NewsWire May 17, 2017

ESSA Pharma Provides Business Update and Announces Financial Results for the Second Quarter Ended March 31, 2017

Canada NewsWire May 15, 2017

Demonetization: Why India Banned 86% Of Its Rupee Notes With No Prior Notice

Benzinga.com  November 15, 2016

Tax Reform Could Boost India ETFs

Benzinga.com  September 14, 2016

Oil Dip, Building Upserge Adds Even More Reasons To Consider India ETFs

Benzinga.com  July 26, 2016

Don't Sleep On India ETFs

Benzinga.com  April 16, 2016